Novonesis AS — Major Shareholding Notification 2016

Mar 29, 2016

In accordance with section 29 of the Danish Securities Trading Act, Novozymes
hereby announces that it has been informed that Baillie Gifford & Co, together
with its wholly owned subsidiary Baillie Gifford Overseas Limited, has
decreased its holding of B shares in Novozymes to 4.99%, previously reported at
7.45% in company announcement no. 25, November 2013.

Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford
Overseas Limited, now holds B shares in Novozymes A/S to a total of 15,646,085
shares of a nominal value of DKK 31,292,170, equivalent to 4.99% of Novozymes
A/S’ share capital and 1.96% of the voting rights.